Vir Biotechnology Inc (VIR) — Long-term Investment Intensity

Latest as of March 2026: 32.5%

Vir Biotechnology Inc (VIR) has a Long-term Investment Intensity of 32.5% as of March 2026. Long-term investments of $332.97 Million represent 32.5% of total assets of $1.03 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Vir Biotechnology Inc for net asset value and shareholders' equity analysis.

LT Investment Intensity

32.5%
LT Investments / Total Assets

Long-term Investments

$332.97 Million
USD

Total Assets

$1.03 Billion
USD

Country

USA
NASDAQ

Vir Biotechnology Inc Long-term Investment Intensity (2018–2025)

This chart shows how Vir Biotechnology Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2018 to 2025. As of March 2026, the intensity stands at 32.5%, reflecting long-term investments of $332.97 Million against total assets of $1.03 Billion USD. Also explore how large is Vir Biotechnology Inc's balance sheet for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Vir Biotechnology Inc (2018–2025)

The table below presents the year-by-year Long-term Investment Intensity for Vir Biotechnology Inc from 2018 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Vir Biotechnology Inc market cap and net worth.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 31.4% $314.57 Million $1.00 Billion ▲ +17.8 pp
2024 13.6% $190.01 Million $1.40 Billion ▲ +8.1 pp
2023 5.5% $105.28 Million $1.92 Billion ▲ +4.6 pp
2022 0.9% $23.93 Million $2.80 Billion ▼ -9.5 pp
2021 10.3% $201.39 Million $1.95 Billion ▲ +5.6 pp
2019 4.7% $24.29 Million $512.07 Million ▲ +1.3 pp
2018 3.4% $6.60 Million $191.60 Million
pp = percentage points